Targeting the Complex I and III of Mitochondrial Electron Transport Chain as a Potentially Viable Option in Liver Cancer Management

The authors reported that depletion of mitochondrial DNA, pharmacologic inhibition of mitochondrial electron transport chain (mETC) complex I/complex III, or genetic of mETC complex I restricted cancer cell growth and clonogenicity in various preclinical models of liver cancer.